Arora Health is the licensed medical group behind the clinical side of Trimi
The risk of hypoglycemia, or low blood sugar, is very low and usually only occurs in patients who take a GLP-1 medication with another medication that is known to cause hypoglycemia, such as insulin
Ideal candidates for this treatment are individuals close to their ideal weight but struggling with localised fat deposits that dont respond to traditional weight loss methods
Glucagon-Like peptide 1 receptor agonists and venous thromboembolism in type 2 diabetes: A target trial emulation
While short-term side effects like nausea are well known, long-term use of Ozempic may lead to: Gastroparesis (stomach paralysis) Ileus, where the intestines temporarily stop moving Bowel obstruction NAION (non-arteritic anterior ischemic optic neuropathy), affecting the optic nerve, potentially causing vision loss Chronic vomiting and dehydration Malnutrition and unintended weight loss Esophageal damage from acid reflux Increased risk of intestinal obstruction For some users, these conditions may become permanent, severely affecting their quality of life
Some patients report improvement with probiotic supplements, though clinical evidence is limited